Study: MDMA therapy for PTSD shows positive results 04:26. The Food and Drug Administration declined Friday to approve an application to treat post-traumatic stress disorder using the drug ...

An FDA panel rejected MDMA-based treatments for PTSD often used with veterans. One advocate shared what the verdict means for the future of mental health care, while doctors stressed supervision.

The U.S. Food and Drug Administration (FDA) has decided not to approve a psychedelic treatment -- along with therapy -- to treat post-traumatic stress disorder (PTSD), according to Lykos ...

HEALTH FDA rejects MDMA as psychedelic-based treatment for mental health, PTSD The agency has requested that Lykos Therapeutics conduct another Phase 3 trial to confirm safety and efficacy ...

A US Food and Drug Administration (FDA) expert panel has found that the benefits of the psychedelic midomafetamine (MDMA) in combination with psychological intervention for the treatment of ...

In June, the FDA's Psychopharmacologic Drugs Advisory Committeevoted 9-2 against MDMA as an effective treatment for PTSD patients, and 10-1 that the drug's benefits do not outweigh the risks.

FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study Drugmaker Lykos Therapeutics said the FDA notified the company that its drug “could not be approved based on data ...

Despite the FDA's rejection of MDMA-assisted therapy, Lykos Therapeutics plans to push ahead for approval, despite internal turmoil and layoffs of 75% of company staff.

There are only two FDA-approved treatments for PTSD. MDMA would be the first to come on the market in decades. Though classified as a Schedule I drug, the FDA granted MDMA "breakthrough therapy ...

Drugmaker Lykos Therapeutics had asked the FDA to approve its MDMA capsules as part of a therapy regimen they argued could be a breakthrough for treating challenging cases of PTSD.. Lykos said the ...

MDMA came close to becoming medicine on Friday, but it missed the mark. The Food and Drug Administration declined to approve what would have been the first psychedelic drug used for the treatment ...

WASHINGTON (AP) — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of ...